Nermina Ferizović

Journal round-up: PharmacoEconomics 42(3)

Nermina Ferizović
May 30, 2024May 29, 2024
Journal round-up

Nermina Ferizović reviews the March 2024 issue of PharmacoEconomics, including articles on decision-modelling and real-world data.

Journal round-up: Health Economics 31(7)

Nermina Ferizović
August 23, 2022August 21, 2022
Journal round-up

Our authors provide regular round-ups of the latest peer-reviewed journals. We cover all issues of major health economics journals as well as other notable releases. Visit our journal round-up log to see past editions organised by publication title. If you’d… Read More »Journal round-up: Health Economics 31(7)

stephen black on Cost-effectiveness thresholds under political pressure: where are the health economists?
I suspect that the root cause of the problem here is not debate about the specific NICE thresholds. It is…
Andrew Briggs on Cost-effectiveness thresholds under political pressure: where are the health economists?
Excellent Chris - love the sentiment here and more to agree on than to disagree about for sure. I guess…
Chris Sampson on There is no evidence that NICE approvals cause harm
A counterfactual in this case could be commissioners not funding (or having not yet funded) the new medicine. That might…

Nermina Ferizović

Journal round-up: PharmacoEconomics 42(3)

Journal round-up: Health Economics 31(7)

Statistical Methods in Economic Evaluation for HTA – Advanced

CHE Policy Forum 2026: Behind the NICE Curtain

ISOQOL 33rd Annual Conference

Research Fellow

Research Fellow

Research Fellow